• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov3
Indivior presents new evidence on SUBLOCADE's impact on opioid use disorder
13:03
Oct30
Indivior released FY2025 Q3 earnings on October 30 Pre-Market (EST), actual revenue USD 314 M (forecast USD 261.92 M), actual EPS USD 0.33 (forecast USD 0.23)
13:30
Indivior released FY2025 9 Months Earnings on October 30 Pre-Market EST, actual revenue USD 882 M, actual EPS USD 0.849
13:30
Indivior Reports Q3 Net Revenue Growth of 2% and Raises Full-Year Guidance
11:39
Oct23
Indivior to Release FY2025 Q3 Earnings on October 30, Pre-Market EST; Forecast Revenue USD 257.66 M, EPS USD 0.23
00:29
Oct15
Indivior plc Announces Clinical Trial Results of SUBLOCADE® for Rapid Induction in Opioid Use Disorder
12:03

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 314 M, Net Income 42 M, EPS 0.33

Jul31
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 302 M, Net Income 18 M, EPS 0.14

Apr24
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 266 M, Net Income 47 M, EPS 0.379

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
CDTX
217.710
+105.41%
+111.720
CYPH
2.750
+56.25%
+0.990
CYCU
6.320
+51.20%
+2.140
WSHP
30.210
+50.90%
+10.190
CMCT
9.250
+36.43%
+2.470
IVVD
2.350
+32.77%
+0.580
TOI
3.970
+28.90%
+0.890
NOMA
7.600
+26.46%
+1.590
CNTB
2.120
+26.19%
+0.440
GTBP
0.9206
+26.14%
+0.191
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy